Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01853670 · ClinicalTrials.gov registry record · NA
Adaptive Radiation Therapy for Head & Neck Cancer Patients
A NA study of Cancer of Head and Neck, sponsored by Beth Israel Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT01853670: Completed NA study of Cancer of Head and Neck, sponsored by Beth Israel Medical Center.
NCT01853670 is a NA study of Cancer of Head and Neck that has completed, run by Beth Israel Medical Center. The registered enrollment target is 6 participants, below the 249-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01853670, a NA study of Cancer of Head and Neck, has completed, sponsored by Beth Israel Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the utility of kilovoltage (kV) cone beam CT imaging to track the dose delivered in head and neck cancer patients, to assess the benefit of cone beam CT to patients set-up for radiation treatment, to determine how shifts based on kV cone beam CT compare to the standard approach (orthogonal pair), and to develop remote access tools (preferably internet-based) so that the MD can approve these plans in real time.
Primary Outcome
This will assessed by CT scan or MRI 4-5 weeks post concurrent chemo.
Conditions Studied
Interventions
- RADIATION concurrent chemo + IGRT
- RADIATION neoadjuvant chemo + IGRT
Study Locations (1)
New York
- Beth Israel Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-08 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT01853670 record still lists
NCT01853670 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 249-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Cancer of Head and Neck appearing as the primary indexed condition, and to 2 interventions - of which concurrent chemo + IGRT is the first listed.
NCT01853670 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01853670 about?
NCT01853670 is a clinical study titled "Adaptive Radiation Therapy for Head & Neck Cancer Patients". The purpose of this study is to determine the utility of kilovoltage (kV) cone beam CT imaging to track the dose delivered in head and neck cancer patients, to assess the benefit of cone beam CT to patients set-up for radiation treatment, to determine how shifts based on kV cone beam CT compare to t...
What is the current status of trial NCT01853670?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2009-08. Estimated completion is 2015-01.
What conditions does trial NCT01853670 study?
This clinical trial studies the following conditions: Cancer of Head and Neck.
What interventions are being tested in trial NCT01853670?
The interventions under investigation include: concurrent chemo + IGRT (RADIATION), neoadjuvant chemo + IGRT (RADIATION).
Who is sponsoring clinical trial NCT01853670?
This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01853670 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer of Head and Neck
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01853670's enrollment target sits among peer trials
6 10th of 9 the lowest of 9 other Cancer of Head and Neck trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer of Head and Neck trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Comprehensive Approach to Head and Neck Cancer Prehabilitation
ACTIVE NOT RECRUITING · NA
-
Onco-primary Care Networking to Support TEAM-based Care
ACTIVE NOT RECRUITING · NA
-
The Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer Surgery
COMPLETED · NA
-
Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers
COMPLETED · NA
-
Single-arm Phase II Study of NDURE for Patients With HNC
COMPLETED · NA
-
A Multicenter Cancer Biospecimen Collection Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia